Pfizer’s Omicron protection lasts less for children 5-11 years old

In the trial published on the MedRxiv website, portal that publishes scientific studies that will be subject to peer review, scientists call attention to the dose of the immunizer. “These results highlight the potential need to investigate alternative dosing of vaccines for children and the continued importance of layered protections, including the use of masks, to prevent infection and transmission,” said Researchers.

Add Comment